Leung Sandra's Form 4 filing
Bristol Myers Squibb CoBMY · filed Jun 7, 2022
- Accession no.
- 0000014272-22-000123
- Filed
- Jun 7, 2022
- Trade date
- Jun 6, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $4.87M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leung SandraCIK 0001199294 | Officer (EVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Common Stock, $0.10 par value | SSaleDisposed | −65,000 | $74.89F1 | −$4,867,850 | 308,627.33 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $74.870 to $74.910, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.